Remidio is an innovative ISO 13485 certified medical device company that seeks to create Healthcare Access by combining the simplicity of product design with cutting edge technology and sustainable business model innovations. The company's CE marked and FDA 510k registered retinal imaging devices have helped screen and impact more than 7.5 million patients in 15 countries globally. Founded in 2009 and headquartered in India, Remidio uses principles of Design Thinking and involves key stakeholders during the product development process – clinicians, patients, and health workers, with a view to designing product solutions that are simple to use, clinically relevant, reliable, and scalable. The company's last investment, a INR1.50B Corporate Round investment, was made on 19 February 2023 and was led by Sun Pharmaceutical Industries.
Remidio
Make it Simple
India
200 employees
Corporate Round
Total: $1.50B
Health Care, Manufacturing +1
General Information
India
BounceWatch is an independent company data service, not affiliated with Remidio. To contact Remidio, visit remidio.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Remidio compare?
A PDF of Remidio and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Remidio soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
From the desk
Is Remidio on your competitive set?
Our desk can watch it and brief you on every move: hiring, funding, leadership, product and pricing.
Book a 7-day ReadoutDiscover More
India Market
Health Care
About Remidio
Business keywords: ISO 13485 certified, medical device company, Healthcare Access, product design, technology innovation, sustainable business model, Design Thinking, retinal imaging, smartphone platform, innovative imaging technologies, ophthalmology, clinical validation, public health, product innovation, patient centricity
Funding Rounds & Investors (3)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Corporate Round | INR1.50B | 1 |
Sun Pharmaceutical Industries
|
19 Feb 2023 |
| Seed Round | Undisclosed | 1 |
|
31 Mar 2022 |
| Series B | Undisclosed | 1 |
Cipher Plexus
|
14 Jan 2016 |
Remidio Alternatives & Competitors
View All Alternatives
EQUASHIELD Closed System Transfer Device and EQUASHIELD Mundus HD
Small changes equal big improvements
We offer solutions to the Medical Devices industry adapted to your situation.
FAQ About Remidio
Source: BounceWatch company record for Remidio, https://bouncewatch.com/company/remidio, updated 30 December 2024. When citing, please name BounceWatch and link this page.
